01 1Hana Pharmaceutical Co., Ltd.
01 1Hana Pharmaceutical Co., Ltd.
01 1Flacainide acetate
01 1South Korea
Registrant Name : Hana Pharmaceutical Co., Ltd.
Registration Date : 2021-03-23
Registration Number : 20210323-211-J-896
Manufacturer Name : Hana Pharmaceutical Co., Ltd...
Manufacturer Address : 133, Jeyakgongdan 3-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do
48
PharmaCompass offers a list of Flecainide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Flecainide manufacturer or Flecainide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Flecainide manufacturer or Flecainide supplier.
A E-0735 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of E-0735, including repackagers and relabelers. The FDA regulates E-0735 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. E-0735 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of E-0735 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A E-0735 supplier is an individual or a company that provides E-0735 active pharmaceutical ingredient (API) or E-0735 finished formulations upon request. The E-0735 suppliers may include E-0735 API manufacturers, exporters, distributors and traders.
click here to find a list of E-0735 suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a E-0735 Drug Master File in Korea (E-0735 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of E-0735. The MFDS reviews the E-0735 KDMF as part of the drug registration process and uses the information provided in the E-0735 KDMF to evaluate the safety and efficacy of the drug.
After submitting a E-0735 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their E-0735 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of E-0735 suppliers with KDMF on PharmaCompass.
